Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters

Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a range of histological findings from the generally benign simple steatosis to steatohepatitis (MASH) which can progress to fibrosis and cirrhosis. Several factors, including the microbiome, may contribu...

Full description

Saved in:
Bibliographic Details
Main Authors: Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, Lina Chen, Elena M. Comelli, David S. Guttman, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Microbiome
Subjects:
Fatty liver
Tissue microbiome
Hepatic immune cells
Hepatic transcriptome
Adipose gene expression
Online Access:https://doi.org/10.1186/s40168-024-02004-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40168-024-02004-7

Similar Items